Related Experiment Video
Updated: Apr 26, 2026

11:02
Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
19.0K
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
Alberto Paniz-Mondolfi1, Rajesh Singh, George Jour
1Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA, albertopaniz@yahoo.com.
Virchows Archiv : an International Journal of Pathology
|July 18, 2014
Summary
Cutaneous carcinosarcoma (CCS) is a rare cancer with epithelial and sarcomatoid parts. Genetic analysis reveals both components share a common origin, with distinct mutations linked to specific subtypes, suggesting targeted therapy potential.
Area of Science:
- Oncology
- Genetics
- Dermatopathology
Background:
- Cutaneous carcinosarcoma (CCS) is an exceptionally rare neoplasm.
- CCS presents a biphasic morphology with both epithelial and sarcomatoid components.
- The histogenesis and biological behavior of CCS are poorly understood, with theories suggesting a single cancer stem cell origin.
Purpose of the Study:
- To investigate the mutational landscape of cutaneous carcinosarcoma (CCS).
- To determine if the epithelial and sarcomatoid components of CCS share common genetic signatures.
- To explore potential correlations between molecular alterations and the epithelial morphotype of CCS.
Main Methods:
- High-depth next-generation sequencing (NGS) was performed on 47 cancer-associated genes.
- Mutational hot spot regions were analyzed in both epithelial and sarcomatoid components of CCS.
- Genetic signatures of distinct tumor elements were compared to assess clonal origin.
Main Results:
- Both epithelial and sarcomatoid components of CCS share a common clonal origin, despite phenotypic differences.
- CCS exhibits molecular heterogeneity, with distinct mutational profiles associated with specific epithelial morphotypes.
- Squamous cell carcinoma-like CCS shows TP53 gene mutations, while basal cell carcinoma-like CCS has a more complex mutational landscape.
Conclusions:
- Cutaneous carcinosarcomas arise from a common progenitor cell.
- Specific molecular signatures correlate with the epithelial differentiation of CCS, indicating distinct subtypes.
- The identified targetable gene pathways offer potential for developing personalized therapies for CCS.

